Oliman, Nelfa .

HRN: 14-01-59  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2024
CEFTRIAXONE 1G (VIAL)
05/16/2024
05/22/2024
IV
2g
OD
UTI
Waiting Final Action 
05/17/2024
METRONIDAZOLE 500MG (TAB)
05/17/2024
05/23/2024
ORAL
500 Mg
TID
E. Coli Infection
Waiting Final Action 
05/18/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/18/2024
05/24/2024
IV
500mg
Q8
Intestinal Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: